Dermatology Updates
All the atest articles, research and news from worlds leading Dermatology Journals. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
- 24 часа
- +3
- 7 дней
- +19
- 30 дней
- –
- Реакции
- 0
- Репосты
- –
- Комментарии
- –
Динамика подписчиков
Подписчиков у канала «Dermatology Updates»: 9 840. Средний охват поста за сутки около 146, вовлечённость 1,5 %.
По дням, последние 30 дней
| Дата | Подписчики | Изменение | Посты | Ср. просмотры поста |
|---|---|---|---|---|
| 11 ноя | 9 840 | +3 | 6 | 124 |
| 10 ноя | 9 837 | 0 | 3 | 212 |
| 9 ноя | 9 837 | +2 | 5 | 280 |
| 8 ноя | 9 835 | +14 | 0 | – |
| 3 ноя | 9 821 | +100 | 1 | 313 |
| 4 окт | 9 721 | – | 0 | – |
Просмотры по возрасту поста
Средние просмотры в каждом возрасте, посты за последние 30 дней.
- 1 ч
- 46
- 3 ч
- 50
- 6 ч
- 81
- 12 ч
- 110
- 24 ч
- 146
- 48 ч
- 201
- 3 дня
- 231
Когда публикует
Время по UTC. 35 постов за 90 дней.
Последние посты
-
• Adding intismeran to pembrolizumab improves recurrence-free survival after melanoma resection INTerpath-001 phase 3 RCT, 1,137 patients with resected stage IIB–IV melanoma: 24-month recurrence-free survival was 82.2% versus 70.0%. Grade ≥3 adverse events occurred in 23.6% versus 20.3%; overall-survival benefit is not established here. Abstract reviewed. NEJM | 11 November 2026 Original study: https://doi.org/10.1056/NEJMoa2609762 Explore more research in this specialty: https://updatesinmedicine.com/research/dermatology
60 просмотров -
Geographic Disparities in Medicare Prescribing of Chemopreventive Therapies and Systemic Agents for Advanced Cutaneous Malignancies, 2013-2023 https://www.jaad.org/article/S0190-9622(26)03916-2/fulltext?rss=yes
128 просмотров -
Clinical Characteristics, Etiologic Associations, and Treatment Outcomes of Pernio https://jamanetwork.com/journals/jamadermatology/fullarticle/2856414
141 просмотров -
Recognizing Autoinflammatory Diseases in Dermatology https://jamanetwork.com/journals/jamadermatology/fullarticle/2856415
119 просмотров -
Errors in Figure 2 and the Methods https://jamanetwork.com/journals/jamadermatology/fullarticle/2856416
106 просмотров -
Diffuse Lip Swelling and Oral Nodules in an Adolescent https://jamanetwork.com/journals/jamadermatology/fullarticle/2856417
101 просмотров -
Dermatology | Research update — 11 November 2026 Brepocitinib improves cutaneous sarcoidosis in a small phase 2 trial BEACON phase 2 (31 participants): 69% on 45 mg achieved clear/almost-clear skin versus 0% on placebo at 16 weeks. Small study; long-term safety remains uncertain. Abstract reviewed. JAMA Dermatol • 2026-11-10 Original article: https://doi.org/10.1001/jamadermatol.2026.5444 Explore more research in this speciality: https://updatesinmedicine.com/research/dermatology
149 просмотров 2 Реакции -
Efficacy and Safety of Brepocitinib in Cutaneous Sarcoidosis https://jamanetwork.com/journals/jamadermatology/fullarticle/2856401
180 просмотров -
Collagen-PMMA scaffolds induce dermal remodeling and immune recruitment distinct from simple volar fibroblast therapy in human skin https://www.jidonline.org/article/S0022-202X(26)03870-4/fulltext?rss=yes
238 просмотров -
Topical sirolimus gel for hyperplastic rosacea: A randomized, double-blind, controlled study and exploration of two-dimensional to three-dimensional approximate protrusion volume (APV) assessment https://www.jaad.org/article/S0190-9622(26)03760-6/fulltext?rss=yes
219 просмотров
-
End-of-Dose Effect as a Guide for Biologic Optimization in Hidradenitis Suppurativa https://jamanetwork.com/journals/jamadermatology/fullarticle/2856181
324 просмотров -
Extracellular vesicles reflect fibroblast and endothelial activation in anti-centromere antibody-positive systemic sclerosis spectrum disease https://www.jidonline.org/article/S0022-202X(26)03797-8/fulltext?rss=yes
322 просмотров -
Repurposing buffered lidocaine with epinephrine for epidermal inclusion cyst cavity irrigation https://www.jaad.org/article/S0190-9622(26)03872-7/fulltext?rss=yes
313 просмотров -
Characterizing Real-World Cutaneous Toxicity of Pegylated Liposomal Doxorubicin Across Multiple Malignancies https://www.jaad.org/article/S0190-9622(26)03875-2/fulltext?rss=yes
310 просмотров -
Ethics of Penalizing Physicians for Delayed/Incomplete Charts https://www.jaad.org/article/S0190-9622(26)03874-0/fulltext?rss=yes
308 просмотров -
Response to Han et al., ‘Infection risk among psoriasis biologic-new users: a cohort study on the French National Health Data System’ https://www.jaad.org/article/S0190-9622(26)03878-8/fulltext?rss=yes
306 просмотров -
Mycetoma in the United States: A Clinical Review https://www.jaad.org/article/S0190-9622(26)03880-6/fulltext?rss=yes
306 просмотров -
Epidermal Differentiation Disorders (EDDs): Translational insights and technical challenges of three-dimensional epidermal, full-thickness, and organoid skin models https://www.jidonline.org/article/S0022-202X(26)03861-3/fulltext?rss=yes
297 просмотров -
Real-world effectiveness of omalizumab in cholinergic urticaria: a 16-week multicenter retrospective cohort study https://www.jaad.org/article/S0190-9622(26)03881-8/fulltext?rss=yes
294 просмотров -
Pregnancy Outcomes and Infertility in Female Patients with Hereditary Leiomyomatosis and Renal Cell Cancer: A Cross-sectional Study from a Canadian Tertiary Referral Centre https://www.jaad.org/article/S0190-9622(26)03886-7/fulltext?rss=yes
287 просмотров
Вопросы о канале «Dermatology Updates»
Сколько подписчиков у канала «Dermatology Updates»?
У канала «Dermatology Updates» (@dermatology_updates) 9 840 подписчиков на 12 ноября 2026 г.
Сколько человек видят пост в канале «Dermatology Updates»?
Средний пост набирает около 150 просмотров за 24 часа, это примерно 1 % подписчиков (ERR).
О чём канал «Dermatology Updates»?
Канал в категории «Здоровье», язык постов: английский. Описание канала: «All the atest articles, research and news from worlds leading Dermatology Journals. Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot»
Какое место занимает канал «Dermatology Updates»?
По числу подписчиков: №102 в категории «Здоровье», №2 059 среди каналов на языке «английский», №2 447 в мире.
Публикует ли канал «Dermatology Updates» рекламу?
За последние 30 дней ни один из 35 постов не помечен как реклама (#ad, Sponsored, «Реклама»). Рекламу без пометки определить нельзя.
Статистика обновлена 18 минут назад.